US EditionAI-powered blood test improves early Lyme disease detection
- Researchers unveiled a new AI-powered blood test for Lyme disease at ADLM 2025 held in Chicago from July 27 to 31, 2025.
- The test responds to the challenges of current two-tier serology, which detects early Lyme disease correctly only 30% of the time and delays diagnosis.
- LymeSeek employs machine learning to evaluate a set of 10 protein antigens, achieving accuracy exceeding 90% in identifying Lyme disease at all stages.
- Holly Ahern, ACES Diagnostics CSO, noted that the test’s accuracy exceeds 90%, ensuring most patients receive an accurate diagnosis along with proper treatment, which greatly reduces the likelihood of developing chronic illness.
- The test is anticipated to launch on the market before the end of 2026, providing an accessible means for early Lyme disease diagnosis that could enhance patient outcomes amid increasing cases linked to climate change.
17 Articles
17 Articles
AI-powered blood test improves early Lyme disease detection
Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard - and that could translate to vastly improved patient outcomes.
Sweetwater Reporter
Breaking research at ADLM 2025: AI poised to revolutionize Lyme disease testing, treatment
CHICAGO, July 28, 2025 /PRNewswire/ -- Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and…
Lyme disease research transformed by thoughtful AI integration, studies show
Today at ADLM 2025 (formerly the AACC Annual Scientific Meeting & Clinical Lab Expo), researchers will unveil a blood test developed with the help of artificial intelligence (AI) that identifies Lyme disease sooner and more accurately than the current standard—and that could translate to vastly improved patient outcomes. A second study highlights how certain generative AI tools can empower adolescents by helping them to gather useful medical inf…
Blood Test for Lyme Disease Achieves Over 90% Diagnostic Accuracy
LymeSeek, a diagnostic test combining multiple blood biomarkers and a machine learning algorithm, has shown over 90% accuracy in diagnosing Lyme disease across all stages, including the early phases where current tests often fail to identify the infection. Aces Diagnostics, the company behind its development, expects the blood test to be commercially available by the end of 2026. Lyme disease is a tick-borne disease that affects 475,000 people …
Coverage Details
Bias Distribution
- 100% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
